RecruitingPhase 4NCT06520410
Safety and Efficacy of 18 mm Short Vitrectomy Probe for Pediatric Vitreoretinal Surgeries
Sponsor
Chang Gung Memorial Hospital
Enrollment
60 participants
Start Date
Mar 5, 2024
Study Type
INTERVENTIONAL
Conditions
Summary
This study aims to study the safety and efficacy of using an 18 mm short vitrectomy probe for pediatric vitreoretinal surgeries and to investigate the surgeon's comfort and reliability of using the shorter probe.
Eligibility
Min Age: 0 YearsMax Age: 18 Years
Inclusion Criteria2
- Patients less than 18 years old
- Need vitrectomy due to various etiologies, including retinopathy of prematurity, familial exudative vitreoretinopathy, persistent fetal vasculature, congenital cataract, lens dislocation, open-globe injury, vitreous hemorrhage, or other vitreoretinal diseases.
Exclusion Criteria1
- Patients who cannot cooperate fully with detailed ophthalmic examinations.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
DEVICEPars plana vitrectomy with a 18 mm short vitrector
Using the shorter 18 mm vitrector for various pediatric vitreoretinal surgeries
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06520410
Related Trials
Genotype-Phenotype Study of Patients With Plaquenil -Induced Retinal Toxicity, With Evaluation of the ABCA4 Gene
NCT011451961 location
National Eye Institute Biorepository for Retinal Diseases
NCT014966251 location
Cell Collection to Study Eye Diseases
NCT014328471 location
Advancing Pediatric Retinal Imaging With Auto-aligned OCT
NCT068415751 location
Longitudinal Observational Study of Diabetic Retinopathy Progression in Type 2 Diabetes Patients
NCT074585161 location